$ETST

Earth Science Tech, Inc. (ETST): Results of Operations and Financial Condition

Earth Science Tech, Inc. (ETST) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Earth Science Tech, Inc. Reports Fiscal Year-End Financial Results for March 31, 2026 MIAMI, June 18, 2026 (GLOBE NEWSWIRE) — Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring

Original reporting
Published Jun 18, 2026, 12:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 18, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ETST
Bullish
medium confidence
Mentioned
$ETST
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ETSTBullishMed
01

Why it matters

FY results show modest top-line growth and improved profitability, alongside continued share repurchases; traders may re-rate the stock ahead of the next quarterly update.

02

Market read

Fresh FY financial metrics plus explicit buyback activity are the main catalysts for near-term positioning and expectations into the next earnings window.

03

What to watch

The filing excerpt emphasizes revenue/net income and assets but provides limited detail on operating cash flow, gross margin trend, and leverage/lease obligations—key for assessing durability into Q1 2027.

Relevance 7/10Novelty 7/10Timing: ahead of the upcoming quarter ending Jun 30, 2026 report

Background

ETST is an OTC strategic holding company building a vertically integrated healthcare platform (telemedicine, compounding pharmacy, fulfillment).

Company-level read

Ticker impact

$ETSTBullishMedium confidence
Context

ETST filed an 8-K with FY ended Mar 31, 2026 results: revenue $35.7M (+8%), net income $3.6M (+11%), and balance-sheet strengthening.

Expected impact

Likely modest positive bias as traders price in improved profitability and continued share repurchases, though OTC liquidity can amplify volatility.

Evidence & confidence

The article discloses specific FY financial results and states buybacks (4.0M shares retired in FY; 3.1M shares bought in fiscal Q1 2027), both actionable for positioning into the next quarterly report.

Market effects

Adds datapoints for vertically integrated telemedicine/pharmacy/fulfillment holding companies on profitability and cash-flow direction, but impact is company-specific.

No clear regional spillover beyond OTC healthcare/telehealth sentiment.

Limited global relevance; primarily affects ETST trading and small-cap healthcare read-through.

Counterpoint

Buyback-driven EPS support may mask underlying operating cash-flow quality or margin sustainability; balance-sheet growth could reflect working-capital swings.

Key entities

  • Earth Science Tech, Inc.

    OTC-listed holding company reporting FY ended Mar 31, 2026 financial results and ongoing share repurchases.

  • Giorgio R. Saumat

    CEO and Chairman who highlighted integration progress and buyback activity.

Related articles

$HMCMed

Honda Will Stop Selling Its Lone Electric Vehicle in the U.S.

AIADA and The Wall Street Journal report Honda Motor will end production of its only U.S. EV, the Prologue SUV, with the 2026 model year as the last. Honda expects sales to continue into early 2027 as inventory clears. The article cites EV sales down 30% YoY in June and notes Honda previously scrapped an EV program tied to $10 billion in costs and its first annual loss as a listed company in 2025.

$CAGMed

Conagra Stock Slashes Dividend

Conagra Brands (NYSE:CAG) said it will cut its annual dividend to $0.70 per share from $1.40, citing cash needs under new CEO John Brase. The company also plans to review non-core assets, aiming to free capital as it faces margin pressure from higher costs and weaker demand, and delays acquisitions until its debt-to-core-profit improves.

$MSTRMedAI 8/10

Michael Saylor’s Bitcoin Treasury Company Strategy Is Falling Apart

Strategy (MSTR), Michael Saylor’s Bitcoin treasury firm, says it will suspend further Bitcoin purchases until its Variable Rate Series A Perpetual Stretch Preferred Stock (STRC) returns to $100 par value. The article cites STRC trading below par and Strategy assembling about $3B cash, including $467M from selling more MSTR shares, as Bitcoin and NAV declined.

$DBVTMedAI 8/10

DBV Technologies S.A.: DBV Technologies Files At-The-Market (ATM) Prospectus for Up to $150 Million of Sales

DBV Technologies said it filed an automatically effective SEC Form S-3ASR shelf registration to refresh its at-the-market program for sales of up to $150 million of American Depositary Shares. The ADSs represent five ordinary shares and the program is under a Sept. 5, 2025 sales agreement with Citizens JMP Securities. Net proceeds would fund manufacturing expansion, BLAs, Viaskin Peanut launch prep, development, and working capital.

$JTAIMed

Jet.AI Inc. (JTAI): Completion of Acquisition or Disposition of Assets

Jet.AI Inc. (JTAI) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. EX-99.3 6 ex99-3.htm EX-99.3 Exhibit 99.3 JET.AI, INC. UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL STATEMENTS The following unaudited pro forma consolidated financial information gives effect to the Separation and related adjustments in accordance with Article 11 of the SEC’s Regu